Bristol-Myers Squibb Stock Forecast & Price Target
Bristol-Myers Squibb Price Target 2026
The Quantum Forecast sees a price target of $65.05 (+2.9%) for Bristol-Myers Squibb in about one month (by Dec 11, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $63.23. Click to see the forecast in the chart.
Bristol-Myers Squibb Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Bristol-Myers Squibb at $63.11 (−0.20%) today around 12 PM ET and at $63.55 (+0.50%) tomorrow around 5:30 AM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Bristol-Myers Squibb Stock 2026: Price Performance
Bristol-Myers Squibb stock has gained 17.2% since the start of 2026 and currently trades at $63.23 (as of Nov 12, 2026). Over the same period the S&P 500 is up 11.0%, putting the stock 6.2 percentage points ahead of the index. Over the past 52 weeks the price ranged between $45.17 and $68.79; it is currently 8.1% below its high of Aug 19, 2026.
Bristol-Myers Squibb Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $67.86 for Bristol-Myers Squibb – +7.3% from today. The range band runs from $45.98 – $89.74: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Bristol-Myers Squibb
There are no user forecasts for Bristol-Myers Squibb yet – be the first to make one.
Make your own forecastAbout Bristol-Myers Squibb
Bristol Myers Squibb is a biopharmaceutical company headquartered in Princeton, New Jersey. Its roots go back to 1887, and the current company was formed through the 1989 merger of Bristol-Myers and Squibb. BMS develops and markets prescription medicines, mainly in oncology, hematology, immunology, cardiovascular disease and neuroscience. Important products include the blood thinner Eliquis (co-marketed with Pfizer), the immunotherapy Opdivo, Revlimid and Pomalyst for blood cancers, and newer drugs such as Camzyos, Reblozyl and the schizophrenia treatment Cobenfy.
The United States accounts for most of its sales. A central theme for the stock is the loss of patent protection on several key drugs, which BMS aims to offset with newer medicines, cell therapies and acquisitions such as Celgene, Karuna Therapeutics and Mirati. U.S. drug pricing regulation, including Medicare negotiations, and clinical trial results are other factors. BMS trades on the New York Stock Exchange under the ticker BMY and is part of the S&P 500.
The current price of Bristol-Myers Squibb stock is $63.23 (+0.78% vs. the previous close). In today's trading the high was $63.85 and the low $62.58.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Bristol-Myers Squibb Stock
What is the Bristol-Myers Squibb stock forecast?
The Quantum Forecast expects Bristol-Myers Squibb to reach $65.05 in about one month (by Dec 11, 2026), a change of +2.9% from the current price of $63.23. Over roughly 10 months (by Sep 2027) the price target is $67.86 (+7.3%).
What is the Bristol-Myers Squibb stock price target?
Quantum Forecast price targets by time frame: 1 month $65.05 (+2.9%), 2 months $58.26 (−7.9%), 6 months $63.43 (+0.3%), 10 months $67.86 (+7.3%). The range band shows the typical fluctuation around these targets.
Will Bristol-Myers Squibb stock go up or down?
In the short term the Quantum Forecast points up (+2.9% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Bristol-Myers Squibb?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.